Extensively drug-resistant tuberculosis: Back to the future

European Respiratory Journal

Volumn 36, Issue 3, 2010, Pages 475-477

  Migliori, G B ^a   Sotgiu, G ^b   Lange, C ^c   Centis, R ^a  

^a IRCCS   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BCG VACCINATION; CLINICAL STUDY; EARLY DIAGNOSIS; EDITORIAL; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HISTORY OF MEDICINE; HUMAN; INFECTION CONTROL; LATVIA; MASS SCREENING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; BCG VACCINE; COMMUNICABLE DISEASE CONTROL; EUROPE; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; MIDDLE AGED; PULMONARY MEDICINE; RISK;

EID: 77956600941     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00025910     Document Type: Editorial

References (14)

1. Styblo K, Meijer J, Sutherland I. Tuberculosis Surveillance Research Unit Report No. 1: the transmission of tubercle bacilli; its trend in a human population. Bull Int Union Tuberc 1969; 42: 5-104.
2. Raviglione MC, Uplekar M. WHO's new Stop TB Strategy. Lancet 2006; 367: 952-955.
3. Marica C, Didilescu C, Galie N, et al. Reversing the tuberculosis upwards trend: the Romanian success story. Eur Resp J 2009; 33: 168-170.
4. Lönnroth K, Jaramillo E, Williams BG, et al. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009; 68: 2240-2246.
5. Migliori GB, Loddenkemper R, Blasi F, et al. 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic? Eur Resp J 2007; 29: 423-427.
6. Rieder HL, ed. Intervention for tuberculosis control and elimination. 2002. International Union Against Tuberculosis and Lung Disease, Paris. www.tbrieder.org/publications/interventions-en.pdf
7. Krivinka R, Drapela J, Kubik A, et al. Epidemiological and clinical study of tuberculosis in the district of Kolin, Czechoslovakia. Bull World Health Org 1974; 51: 59-69.
8. Broekmans JF, Migliori GB, Rieder HL, et al. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 2002; 19: 765-775.
9. Erkens CGM, Kamphorst M, Abubakar I, et al. Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J 2010; [In press DOI: 10.1183/09031936.00201609].
10. Migliori GB, Besozzi G, Girardi E, et al. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Resp J 2007; 30: 623-626.
11. Sotgiu G, Ferrara G, Matteelli A, et al. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J 2009; 33: 871-881.
12. Migliori GB, Ortmann J, Girardi E, et al. Extensively drug-resistant tuberculosis, Italy and Germany. Emerg Infect Dis 2007; 13: 780-782.
13. Migliori GB, De Iaco G, Besozzi G, et al. First tuberculosis cases in Italy resistant to all tested drugs. Euro Surveill 2007; 12: E070517.1.
14. Leimane V, Dravniece G, Riekstina V. Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004. Eur Respir J 2010; 36; 584-593.